Multivariate analysis demonstrated that higher HOXB-AS3 expression was an independent poor prognostic factor for OS in primary MDS patients, irrespective of other poor prognostic factors, including higher IPSS scores and adverse risk mutations (Table 2). Here, PDS5B is linked to myelodysplastic syndrome.